Outlook to keep ECB on a dovish normalization path

Weaker data are set to trigger a downward adjustment in the ECB’s macro outlook at the Dec 13 meeting. Yet comments from ECB officials suggest that the growth narrative is still viewed as fundamentally intact. At the press conference a dovish tone is set to prevail emphasizing the contingency of the policy path.

Highlights:

  • Weaker data are set to trigger a downward adjustment in the ECB’s macro outlook at the Dec 13 meeting. Yet comments from ECB officials suggest that the growth narrative is still viewed as fundamentally intact. At the press conference a dovish tone is set to prevail emphasizing the contingency of the policy path.
  • We see the ECB ending QE in December and leaving rates constant at least throughout summer 2019. However, given the latest data and higher risks, we now look for a first deposit rate hike only in December 2019.
  • We look for the announcement of an APP reinvestment period of three years to keep the term premium down but a tilt towards longer dated bonds (“operation twist”) will be hard to engineer. When outlining the details of its reinvestment policy, the ECB may hint at some flexibility in shifting from government to corporate bonds.
  • We do not expect a new TLTRO announcement as it would water down the normalization. But the ECB will not close the door; the mid-2019 cliff effect will need to be addressed if financial conditions or the economy deteriorate further.

Read the full publication below.

OUTLOOK TO KEEP ECB ON A DOVISH NORMALIZATION PATH

RELATED INSIGHTS

Generali Global Infrastructure launches two infrastructure funds to support the European recovery
Milan – Infrastructure assets are considered key in re-shaping a sustainable and resilient recovery path for Europe together with a greener, more digital and people-centered world. To support this transformational shift Generali Global Infrastructure1 (GGI), a boutique focused on infrastructure debt and part of Generali Group’s multi-boutique asset management platform, has launched two infrastructure funds supporting the European recovery.
COVID-19 FACTS & FIGURES
Pfizer and BioNTech candidate Covid-19 vaccine showed to be 95% effective in early analysis, an even better result compared to data released last week. Moderna candidate Covid-19 vaccine showed to be 94.5% effective in early trials involving 30,000 people. Switzerland announced ICU beds reached full capacity and no extra units are available. Oxford and AstraZeneca Covid-19 vaccine test results are expected by late December.
EUROPEAN DEFAULTS LIKELY TO STAY LOW
Since March, credit markets have retraced a large part of the Covid-related spread widening, alongside rebounding risk sentiment. Although the rally has been substantial, it has remained defensive with IG outperforming HY on a beta- adjusted basis. The main reason in our view have been concerns about rising defaults.